Picture of Ackermans & Van Haaren NV logo

ACKB — Ackermans & Van Haaren NV News Story

0.000.00%
be flag iconLast trade - 00:00
IndustrialsConservativeLarge CapNeutral

Brief: Ackermans & Van Haaren Leads EUR 60 Million Series B Financing Round For Confo Therapeutics

July 26 (Reuters) - Ackermans & Van Haaren NV  ACKB.BR :
    * ACKERMANS & VAN HAAREN NV - LEADS  EUR 60 MILLION SERIES B
FINANCING ROUND  FOR CONFO THERAPEUTICS
    * ACKERMANS & VAN HAAREN NV - COMMITS EUR 15 MILLION IN THE
SERIES
B FINANCING ROUND
    * ACKERMANS & VAN HAAREN NV - PROCEEDS TO SUPPORT PHASE 1
CLINICAL
TRIALS FOR TWO PROPRIETARY PROGRAMS, AND TO  ADVANCE TWO
ADDITIONAL PROGRAMS TO INVESTIGATIONAL NEW DRUG (IND) APPROVAL

Source text for Eikon:  ID:nGNEL7WCn 
Further company coverage:  ACKB.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Ackermans & Van Haaren NV

See all news